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Abstract
Until the late 1980s, gastroenterology (GE) was consid-
ered a subspecialty of Internal Medicine. Today, GE also 
incorporates Hepatology. However, Digestive Oncology 
training is poorly defined in the Hepatogastroenterology 
(HGE)-curriculum. Therefore, a Digestive Oncology cur-
riculum should be developed and this document might 
be a starting point for such a curriculum. HGE-specialists 
are increasingly resisting the paradigm in which they 
play only a diagnostic and technical role in the manage-
ment of digestive tumors. We suggest minimum end-
points in the standard HGE-curriculum for oncology, and 
recommend a focus year in the Netherlands for Diges-
tive Oncology in the HGE-curriculum. To produce well-
trained digestive oncologists, an advanced Digestive 
Oncology training program with specific qualifications in 
Digestive Oncology (2 years) has been developed. The 
schedule in Belgium includes a period of at least 6 mo to 
be spent in a medical oncology department. The goal of 
these programs remains the production of well-trained 
digestive oncologists. HGE specialists are part of the 
multidisciplinary oncological teams, and some have been 
administering chemotherapy in their countries for years. 
In this article, we provide a road map for the organiza-
tion of a proper training in Digestive Oncology. We hope 
that the World Gastroenterology Organisation and other 
(inter)national societies will support the necessary certi-
fications for this specific training in the HGE-curriculum. 
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Until the late 1980s, gastroenterology (GE) was consid-
ered a subspecialty of  Internal Medicine. However, since 
then, GE has become more complex, in both endoscopy 
and drug therapy, and the speciality now also incorpo-
rates Hepatology. We now train Hepatogastroenterolo-
gists (HGE-specialists). It is a challenge to develop a 
training program that will produce HGE-specialists who 
are competent in all aspects of  HGE by the end of  their 
program[1,2].
In 2002, the Dutch Board for Hepatogastroenterol-
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ogy extended GE training to 4 years, with a Common 
Internal Medicine Trunk of  2 years[3]. In the final year of  
training, a fellow subspecializes, if  possible/desirable, in 
advanced endoscopy, neuromotility, hepatology, or (di-
gestive) oncology. Training in hepatology has been well 
defined[4,5]. Digestive Oncology training is currently poor-
ly defined[1]. The European Board for Gastroenterology 
and Hepatology has defined subspecialties in advanced 
endoscopy, hepatology, clinical nutrition, and, indeed, 
Digestive Oncology. However, a proper curriculum is 
lacking (http://www.eubog.org)[6]. The World Gastroen-
terology Organisation (WGO) formulated a document 
outlining standards for HGE training[5]. However, again 
Digestive Oncology was poorly defined. Therefore, a Di-
gestive Oncology curriculum needs to be developed and 
subjected to regular revision. This document serves as a 
starting point for such a curriculum. 
DIGESTIVE ONCOLOGY
Today, there are remarkable opportunities for those seek-
ing a career in Digestive Oncology[1,7]. The revolution in 
molecular biology, advances in interventional endoscopy 
and anti-cancer therapies, as well as the management of  
subsequent treatment-related side effects, have perma-
nently changed the way we care for our patients with di-
gestive tumors. HGE-specialists are increasingly resisting 
the paradigm in which they play only a diagnostic or tech-
nical role in the care of  digestive tumors. They now per-
ceive the empty space they need to fill with their knowl-
edge. HGE-specialists are pre-eminently competent to 
organize supportive care around the Digestive Oncology 
patient. They recognize the caveats in the poor nutritional 
condition of  the patient and are able to immediately take 
supporting measures that are necessary for completion 
of  the patient’s treatment. This also holds true for situa-
tions in which patients experience toxicity induced by dif-
ferent anti-cancer treatments. A new generation seeks to 
assume this more central role in the multidisciplinary care 
of  our patients. With proper training, we see no reason 
why future generations of  gastroenterologists should be 
barred from the delivery of  anti-cancer therapies, because 
some might term it “chemotherapy”.
Minimally invasive laparoscopic approaches have been 
developed for almost all digestive tumors, and image-
guided intervention is providing an innovative therapeu-
tic option for early cancers[8]. Modern evidence-based 
“outcomes research” provides an objective tool for as-
sessing clinical results. Patient-completed questionnaires 
and standardized assessment of  individual preferences 
have helped us to understand survivorship issues among 
Digestive Oncology patients, including the long-term ef-
fects of  treatment on quality of  life[9,10]. 
The HGE-specialist has the immense advantage that 
he/she has can both recognizing malnutrition or ob-
structing symptoms threatening the patient’s condition in 
an early state, can subsequently visualize this endoscopi-
cally, and can then take the necessary measures to resolve 
such devastating situations. Obviously, full insight into 
the possible treatment plan for this vulnerable patient 
group is warranted. 
Surgical excellence remains critically important in the 
field of  Digestive Oncology. Despite the development of  
modern anti-cancer drug therapy, (intra-operative) radio-
therapy, and the combined use of  these treatment modali-
ties, the need for optimal surgery has not been eliminated. 
Rather, the pre-operative use of  such therapies has chal-
lenged surgeons to develop the necessary skills to oper-
ate on highly pre-treated tumors, whilst simultaneously 
reducing the burden of  surgical morbidity. Similarly in-
duction chemo(radio)therapy for oesophageal and gastric 
cancers has also expanded the role of  surgery, by allow-
ing the resection of  some cancers previously considered 
inoperable[11,12]. Future leaders in Digestive Oncology 
must be skilled gastroenterologists and surgeons capable 
of  advanced endoscopy, laparoscopic techniques, and 
image-guided therapy. They must also be scholars, well 
versed in the nuances of  modern diagnostic and staging 
procedures, fully appreciative of  the benefits and limita-
tions of  anti-cancer therapy (chemotherapy, immunologi-
cal, and targeted therapy) and radiation therapy (including 
chemoradiation).
Comprehensive training also requires exposure to re-
search, either in the basic sciences, translational research, 
and/or clinical trials. This will prepare future HGE-
specialists to explore hypotheses about digestive tumors 
in an effort to improve patient care.
SOCIETIES FOR DIGESTIVE ONCOLOGY
The European Society of  Digestive Oncology (ESDO) 
was founded in 2008 (http://www.esdo.com). Currently, 
more and more academic centres are offering fellowships 
in Digestive Oncology. According to the ESDO mem-
bership details, essential requirements of  the digestive 
oncologist include: expertise in multidisciplinary care, 
the ability to perform and understand the limitations of  
complex tumor treatments, a clear understanding of  the 
biology and science of  digestive tumors, and the ability 
to collaborate in (translational) research. We suggest that 
active membership of  ESDO should be encouraged for 
HGE-specialists who devote > 50% of  their total pro-
fessional activity to the field of  digestive tumors, who 
have presented at least one oncology paper in a national 
meeting, are board certified by the European Board of  
Gastroenterology and Hepatology (http://www.eubog.
org) or the respective equivalent in their country of  ori-
gin, and have additional oncology experience following 
formal HGE training. The goal of  advanced training in 
Digestive Oncology is to enhance knowledge and skills 
beyond the expertise obtained during a normal HGE 
residency program. The duration of  advanced fellow-
ship training might be 24 mo, with a minimum of  12 mo 
of  clinical exposure during the formal 6 years of  HGE 
training (focus year) and 12 mo of  formal Digestive On-
cology. If  applicants have completed research in Diges-
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tive Oncology, for example a PhD under the auspices of  
governing bodies such as ESDO (or equivalent in their 
country), they might apply to have the 6 mo research 
requirement waived during their 24 mo of  advanced fel-
lowship training in Digestive Oncology: this should be 
discussed.
PROGRAMS IN DEVELOPMENT
All training programs are required to provide a structured 
educational experience at an advanced level to ensure 
that trainees acquire the knowledge and skills necessary 
to gain expertise beyond that acquired in the standard 
HGE residency[1]. Access to patient care and multidisci-
plinary team discussions with medical oncologists, radia-
tion oncologists, surgeons, pathologists, and radiologists 
who have expertise in digestive tumors are an additional 
requirement for the trainees. Programs must provide 
structured clinical opportunities for trainees to develop 
advanced skills in interventional endoscopy. Each fellow 
on the advanced Digestive Oncology program should be 
involved in at least 100 major interventional procedures 
for the treatment of  digestive tumors. Additionally, a re-
search component should be discussed with structured 
supervision for at least 6 mo. If  basic science laboratory 
training is offered, the necessary facilities must be avail-
able under the supervision of  a trainer who has dem-
onstrated at least a national reputation in research, as 
evidenced by publications in peer-reviewed journals, and 
membership of  digestive oncological societies. As an ex-
ample of  one of  the Dutch HGE-approved fellowships 
for a focus year in formal HGE training, the following 
section describes the suggested curriculum for Digestive 
Oncology.
DIGESTIVE ONCOLOGY IN THE DUTCH 
TRAINING OF HGE-SPECIALISTS (FOCUS 
YEAR)
In the Netherlands, during the last year of  HGE train-
ing, it is possible to focus on Digestive Oncology[3]. In 
this year, a minimum of  six sessions per week must be 
spent on oncology-related activities in the context of  the 
focus area. The content of  the training within the profes-
sional body and the terms for the fellowship have been 
designed under the auspices of  the National Board for 
Hepato-Gastroenterology.
END OF TRAINING COMPETENCIES
Knowledge
Knowledge of  the duties/remit as described by the end 
of  training competencies for general HGE-specialists, 
with particular emphasis on anti-cancer drug treatment 
and radiotherapy treatment possibilities; knowledge of  
primary and secondary prevention of  digestive tumors; 
knowledge of  hereditary cancer and polyposis syndromes 
affecting the digestive tract; knowledge of  the rarer di-
gestive tumors, such as anal carcinomas, hepatocellular 
carcinomas, GI-lymphomas (MALT-lymphomas and En-
teropathy Associated T-cell lymphomas), GIST tumors, 
neuro-endocrine tumors, cystic pancreas tumors; knowl-
edge of  advanced endoscopic techniques for diagnosis, 
staging, and treatment of  pre-malignant disorders of  the 
gastrointestinal tract, such as chromo-endoscopy, Endo-
scopic Ultrasonography (EUS), ablative techniques, and 
endoscopic mucosal resection; knowledge of  palliative 
care for malignant digestive disorders and early recogni-
tion patients in need of  nutritional support; and knowl-
edge of  side-effects of  different anti-cancer treatment 
modalities.
Skills
Skill in procedures such as those described by the end of  
training general HGE-specialists; optional (overlap with 
focus year of  advanced endoscopy); endoscopic treat-
ment of  malignant stenoses of  the oesophagus, stomach, 
duodenum, and colon; recognition and identification of  
premalignant lesions; endoscopic treatment of  anasto-
motic leakages after surgery; percutaneous endoscopic 
gastrostomy (PEG) placement; endoscopic ultrasound 
(EUS) and EUS-guided fine needle aspiration (FNA); 
endoscopic ablative treatment, such as Photo-Dynamic 
Therapy, electrocoagulation, argon plasma coagulation 
(APC), and intraluminal radiotherapy; and endoscopic 
mucosal resections in the oesophagus, stomach, duode-
num, and colorectum.
Learning environment
A minimum of  two HGE-specialists with an interest in 
oncology, one of  whom is recognised as a mentor by the 
National Society in the focus area; weekly multidisciplinary 
oncology meetings; and practice within the department 
in EUS, including diagnostic biopsy, endoscopic ablative 
treatment methods, intraluminal radiotherapy, endoscopic 
treatment of  malignant stenoses in the oesophagus, stom-
ach, duodenum, and colorectum, and endoscopic mucosal 
resections. The department should be active in the de-
velopment of  newly targeted endoscopic diagnostic and 
therapeutic modalities for pre-malignant abnormalities. 
Within the hospital the personnel should include: regis-
tered medical oncologists (internist-oncologist), minimum 
two; registered surgical oncologists (surgeon-oncologist), 
minimum two; radiation oncologists, minimum two; and a 
clinical geneticist, possibly seconded or on a consultative 
basis.
Training
(Endoscopic) activities, based on the end of  training tar-
gets; medical oncology, minimum 40 sessions; radiation 
oncology, minimum 10 sessions; attendance at oncologi-
cal/surgical interventions (oesophageal resection, gastric 
resection, pylorus-preserving pancreatoduodenectomy 
(PPPD), liver resection, colon resection, total mesorectal 
excision (TME)-resection, only once); a minimum of  10 
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sessions of  pathology; and a minimum of  10 sessions of  
clinical genetics.
Participation in discussions and structured 
consultations 
At least weekly multidisciplinary oncology meetings with 
minimum participants to include an internist-oncologist, 
an oncological surgeon, a radiotherapist, a radiation on-
cologist, a pathologist, and a nuclear medicine specialist. 
At least one meeting per quarter should include a clinical 
geneticist.
Scientific activities
Conference attendance: minimum of  one attendance at 
an international clinical oncology conference (ASCO, 
ESMO, ESDO) or an international interdisciplinary Di-
gestive Oncology conference. The fellow should take an 
active part in a research project in the area of  oncology, 
preferably in the context of  a research degree. The fel-
low should write at least one scientific publication on an 
oncology-related subject and present at least one abstract 
concerning an oncology-related subject at a national or 
international conference.
Quality control
GI training and quality inspection at a regular interval of  
at least 5 years, organized and supervised by the national 
society for HGE.
Educational supervision
Trainers are required to provide appraisal during train-
ing and assessment that contributes to the evidence of  
competence of  the fellow, who is recommended to pro-
vide a portfolio of  assessed cases. Trainers must provide 
adequate on-site supervision for trainees at all times, as 
defined in the curriculum. Satisfactory assessments from 
trainers and completed log books that demonstrate that 
the fellow meets the criteria of  competence are required 
for a fellow to be assessed as competent in Digestive On-
cology (focus year).
Advanced Digestive Oncology training in Belgium (2 years) 
The HGE-specialist of  the future, or at least some of  
them, desire continuous care for their digestive tumor 
patients. To treat them, however, HGE-specialists should 
acquire skills. The necessary skills are currently beyond 
those taught during the HGE training in most coun-
tries. Since the beginning of  2010, there has been official 
recognition of  HGE-specialists with a specific qualifica-
tion in Digestive Oncology in Belgium[13]. To obtain this 
qualification, the candidate has to do one oriented year 
(focus year) during the main training years for HGE and 
one additional year. Six months of  this training period 
needs to be spent in a medical oncology department. 
The curriculum will be focused on: (1) the pathophysiol-
ogy of  the different types of  gastrointestinal tumors; (2) 
diagnostic management; (3) development of  a multidisci-
plinary treatment plan; (4) the correct administration of  
systemic treatments, including chemo- and immunothera-
py, biological and genetic treatments; (5) the management 
of  side effects; (6) the management of  tumor-related 
and iatrogenic complications; (7) cancer registration; (8) 
multidisciplinary approaches; (9) the evaluation and con-
ception of  clinical trials; and (10) active participation in 
palliation. To maintain their recognition, more than 50% 
of  the specialist’s working time has to focus on oncology.
Standards for safe administration of treatment
Chemotherapy ordering, preparation and administration; 
patient education and informed consent; staff  education 
and training; assessing how patients respond to treat-
ment; monitoring patient-related toxicity.
DIGESTIVE TUMORS
Risk factors in HGE-cancers; indicators for endoscopy 
in diagnosis; indicators for endoscopy in staging; indica-
tors for nutritional support; combined modality therapy; 
role of  palliative chemotherapy; chemoprevention; (fam-
ily) screening; and genetic testing. The Curriculum of  
the European Society for Medical Oncology (ESMO) 
and the American Society of  Clinical Oncology (ASCO) 
described in the Global Core Curriculum for training in 
Medical Oncology provides the main framework for the 
training for Digestive Oncology[14].
FUTURE EUROPEAN BOARD PROGRAM 
DESCRIPTION
The goal of  the future European HGE-Board fellowship 
program remains to produce, for the local countries, a 
framework of  well-trained digestive oncologists who will 
be leaders in academic Digestive Oncology and be quali-
fied to promote improvements in national care to reduce 
the incidence, morbidity, and mortality of  digestive can-
cer, and improve quality of  life[6]. Disease management 
teams include specific cancer sites (oesophageal, gastric, 
colorectal cancer (CRC), pancreatic, liver, hepatobiliary, 
anal, neuroendocrine, and gastrointestinal stroma cell 
tumors) and comprise surgeons, (digestive) oncologists, 
radiation oncologists, palliative care physicians, dieti-
cians, pathologists, radiologists, nuclear physicists, clinical 
geneticists, and laboratory researchers. In case of  GI-
lymphomas, such management teams should also include 
hematologists. Working in these disease management 
teams, fellows have an opportunity to participate in the 
development of  multidisciplinary management plans for 
patients, as well as the design and pursuit research oppor-
tunities, including clinical trials. The role of  these teams 
includes, for example, the enhancement and promotion 
of  CRC-screening, early tumor detection, primary and 
secondary prevention, and management of  pre-malignant 
or malignant HGE diseases, as well as the translation of  
research into the clinical setting.
CLINICAL EXPERIENCE
The future program of  the European Board’s curriculum 
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should be designed to provide the fellow with a practical 
knowledge of  the most up-to-date diagnostic and thera-
peutic strategies for digestive tumors[15]. The aim is to 
develop familiarity with, and stimulate interest in, clinical 
and laboratory studies designed to advance knowledge in 
the field. The responsibility for clinical care is shared by 
the faculty, fellows, residents, medical students, and nurse 
practitioners. Fellows are directly involved in the manage-
ment of  patients with digestive tumors. The volume and 
nature of  the clinical experience is such that the fellow 
has an opportunity to participate in the management of  
patients with all types and stages of  digestive tumors. 
TRAINING CRITERIA
During the general HGE training, fellows should acquire 
better theoretical knowledge of  the etiology, patho-
genesis, natural history, clinical manifestation, work-up, 
and treatment of  digestive tumors[15]. Such knowledge 
should include nutrition, if  necessary pre-operative, dur-
ing treatment, and for palliative care. Knowledge of  lo-
gistics, health care economics, and medical ethics seems 
mandatory[16]. The fellow must have observed, and been 
responsible for, adequate numbers of  patients with di-
gestive tumors, both as inpatients and outpatients. Such 
patients include those with complications encountered 
during work-up, surgery, chemotherapy and radiotherapy. 
They should also include those in need of  enteral and 
parenteral nutritional support, such as nasogastric feed-
ing, PEG-/percutaneous endoscopic jejunostomy (PEJ)-
feeding. Close cooperation with a hospital dietician 
should be part of  this. 
Clinical experience must be gained in paid positions, 
obtained by open and transparent competition. Teach-
ing must be an integral part of  this Digestive Oncology 
program. Supervision of  clinical work should be defined 
locally.
DIDACTIC EDUCATION
The goal of  the advanced 24-mo educational program 
of  the European Board of  HGE is to provide a broad 
view of  all aspects of  digestive tumours, and a familiarity 
with diagnostic and therapeutic approaches. Rotations in 
medical oncology for at least 4-8 mo are supplemented 
by lectures on systemic therapy. In an oncology setting, 
staff  work in the presence of  patients with cancer every 
day. The emotional impact of  this work must be recog-
nized, and fellows should be coached on this, not only 
to appreciate the impact of  the cancers on the patients, 
but also on the impact of  oncology care on non-licensed 
support staff[17].
ONCOLOGY IN THE STANDARD HGE-
CURRICULUM
The description of  the end of  training competency, 
learning environment, and the training are as indicated in 
the Gastroenterology Consensus Document in the Neth-
erlands dated 14 December 2004[1,3].
With relation to oncology, we can quote from the cur-
rent terms the following passages: (1) General end of  
training competency: medical aspects: prevention; knowl-
edge of  preventative medicine with emphasis on pre-
malignant disorders of  the digestive tract; and (2) specific 
syndromes: (a) the specialist is experienced in the area of  
malignant disorders of  the digestive tract; and (b) during 
the training in HGE there should be sufficient attention 
and space for the following basic courses: (i) Clinical ge-
netics; and (ii) Clinical epidemiology.
An important part of  the workload of  HGE-special-
ists involves oncology. Areas in which the HGE-specialist 
must have expertise and skills include: (1) prevention, 
screening and surveillance; (2) diagnosis and staging; (3) 
endoscopic therapy, both curative and palliative; (4) sup-
portive treatment, for example in relation to nutrition; 
and (5) diagnosis and treatment of  both short-term and 
long-term complications of  oncological therapies, for 
example radiation damage and drug-induced treatment 
induced mucositis.
CRITERIA FOR THE END OF THE 
TRAINING COMPETENCY IS SPECIFIED 
AS FOLLOWS
Knowledge
Basic knowledge of  epidemiology and pathogenesis of  
the frequently occurring digestive tumors; knowledge 
of  symptomatology, diagnosis and staging of  frequently 
occurring digestive tumors; basic knowledge of  rare 
digestive tumors; basic knowledge of  molecular tumor 
biology; knowledge of  familial tumor syndromes, such 
as familial adenomatous polyposis (FAP), hereditary 
non-polyposis colorectal cancer (HNPCC), and MYH-
associated polyposis (MAP), including surveillance advice 
and knowledge of  indications for referral to clinical ge-
netic centres; knowledge of  surveillance (pro’s and cons) 
of  premalignant disorders, such as Barrett’s oesophagus, 
intestinal metaplasia and atrophy in the stomach, adeno-
matous polyps, and ulcerative colitis; knowledge of  policy 
with relation to the follow-up after anti-cancer treatment; 
knowledge of  the screening of  the general population 
for pre-malignant and malignant disorders of  the diges-
tive tract; knowledge of  the current range of  abdominal 
imaging techniques with relation to oncological diagnosis, 
and their indications; familiarity with microscopic pre-
malignant and malignant disorders of  the digestive tract; 
knowledge of  endoscopic treatment possibilities with 
curative and palliative intent; basic knowledge of  other 
treatment modalities, such as surgery, radiotherapy, and 
chemotherapy; basic knowledge with relation to the de-
velopment of  neo-adjuvant and adjuvant treatments of  
the different digestive tumors; knowledge of  nutrition as 
an integral part of  treatment and of  the different ways 
that feeding can be administered; and knowledge of  di-
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gestive problems in patients with non-gastroenterological 
tumors, for example radiation enteritis and proctitis, and 
the metastasis and ingrowth of  other tumors into the di-
gestive tract (breast cancer, melanoma).
Skills
Conventional endoscopic diagnosis of  tumors of  the 
digestive tract; global assessment of  current abdominal 
imaging techniques in the context of  oncological diagno-
sis; endoscopic resection of  colorectal and gastric polyps; 
treatment of  mild to moderately severe radiation proctitis 
with the use of  APC; PEG placement; drainage of  malig-
nant ascites; delivery of  bad news and the counselling of  
patients and their family members.
Learning environment
Each HGE training clinic must have the necessary facili-
ties to integrate oncological aspects of  digestive medicine 
into general training. The HGE-specialist should partici-
pate in multidisciplinary oncological discussions concern-
ing abdominal tumors.
Training
There is no reason to introduce a separate oncological 
training period into the general HGE training program. 
This is only required for those individuals choosing to 
specialize in Digestive Oncology (focus year). Through 
local, regional and national teaching courses, much of  the 
knowledge that is not accumulated in daily practice can 
be acquired to fulfil the end of  training competency.
Review
To develop anonymous national assessment tests. Test 
frequency of  once every 2 years.
Monitoring
Through HGE trainer.
Quality control
HGE training and quality inspection.
HGE-TRAINING AROUND THE WORLD
Differences in HGE training between the USA/Europe, 
India/China and, for example Sub Saharan Africa, are 
magnified by the obvious resource gaps between Third 
and First World countries. Redesigning training programs 
more efficiently would be another goal based on a com-
mon trunk system for HGE[18]. India and China, with a 
common trunk of  Internal Medicine for 2-3 years, have 
incorporated private hospitals into their programs. Well-
equipped private hospitals should be used during Diges-
tive Oncology focus years in the East and West. In East-
ern Europe, Ministers of  Health recently suggested that 
training for HGE should be reduced to 4 years in total[19]. 
Arguments about specialist training are getting louder as 
governments get poorer because the current credit crisis. 
However, a properly organized scheme for Digestive On-
cology is mandatory to give patients the best chance of  
benefiting from national resources. 
CONCLUSION
In this article, we present the critical elements of  multi-
disciplinary fellowship training for the digestive oncolo-
gist, and suggest minimal competencies for the standard 
HGE-curriculum. Digestive Oncology is substantially 
under-represented in the undergraduate and postgraduate 
curricula of  present day HGE training programs. Cancer 
prevention and screening, in particular, have suffered 
from poor exposure in the past[20,21]. 
At the present time, the HGE specialist organizes 
the work-up, endoscopic-intervention of  early diges-
tive tumors, nutritional support and palliation of  HGE- 
oncological patients. Interestingly, HGE-tumors are 
diagnosed by endoscopists often at the tip of  their scope. 
Chemotherapy (neo-adjuvant) should be included based 
on competence[11,12,22]. HGE-specialists have an essential 
role in the treatment of  complications of  digestive cancer 
and cancer therapy, from the placement of  stents to the 
relief  of  obstructions and feeding tubes/PEG’s to help 
anorexia and malnutrition, to the management of  radio-
therapy-induced bowel disorders. Malnutrition increases 
complications and reduces tolerance to systemic treat-
ment[23]. The HGE-specialist has a critical role in primary 
and secondary prevention of  digestive tumors. However, 
just preventing a polyp from becoming a tumor, just 
making a diagnosis, just staging a tumor by EUS, just 
making referrals, just treating early complications of  the 
oncologist, radiotherapist or surgeons, just taking care of  
palliation are unlikely to be “only” roles of  HGE-special-
ists nowadays. It is this idea of  expansion of  the scope of  
HGE-units that will necessitate advanced Digestive On-
cology training for a minority of  HGE-specialists. What 
about immunotherapy in cancer, such as is performed 
for IBD? What about chemotherapy, a red line for HGE-
specialists? Subspecialization within medical oncology 
has occurred to provide the required expertise needed 
to provide optimal patient care. The field of  Digestive 
Oncology is also rapidly evolving. It requires specialized 
knowledge and skills to appropriately and safely adminis-
ter various anti-cancer drug agents, with subsequent man-
agement of  their toxicities. Some HGE-specialists trained 
as sub-specialists of  Internal Medicine already administer 
chemotherapy in their countries. Maintaining the continu-
ity of  patient care is certainly a worthwhile goal. 
In our opinion, HGE-specialists with advanced oncol-
ogy training should be part of  the gastrointestinal oncol-
ogy team and be able to administer anti-cancer therapy in 
the years to come. In this article we provide a road map 
to organize this training. The scope and personalization 
of  the HGE-curriculum is our major challenge, and one 
that will change HGE once again in the coming years. 
The proper positioning of  Digestive Oncology is an im-
portant part of  this. We hope that the WGO, American 
Gastroenterology Association, the European Board of  
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Hepatogastroenterology, and other (inter)national socie-
ties will organize the necessary certification for this HGE-
specialization.
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